相关实验视频

Updated: Jun 11, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.0K

下一代测序用于晚期EGFR/ALK阴性非小细胞肺癌的成本效益

Dong-Won Kang1, Sun-Kyeong Park2, Sokbom Kang3

  • 1School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, Republic of Korea.

Lung cancer (Amsterdam, Netherlands)
|October 4, 2024
PubMed
概括

与顺序单基因测试 (SGT) 相比,下一代测序 (NGS) 对晚期EGFR/ALK阴性非小细胞肺癌 (NSCLC) 不具有成本效益. 然而,NGS提供了生存益处,为临床和覆盖决策提供了信息.

关键词:
经济效益性 经济效益性肺癌是一种肺癌.这是下一代测序.单基因测试是一种单基因测试.

更多相关视频

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

16.7K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.8K

相关概念视频

Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.4K